skip to Main Content

Resources

How pharmacies can make adherence cost-effective

Incentives drive pharmacy focus on adherence As pharmacies are increasingly held to quality incentives, they are getting proactive about adherence. For example, in March 2019, Walgreen Co. started hiring pharmacists specifically tasked with helping chronic disease patients to become more…

Read More

Making the most of DIR contracts: Where to invest and why

Highlights from a conversation with William Grambley, Chief Operating Officer at AllazoHealth. Got questions? William can be reached at william.grambley@allazohealth.com DIR (Direct and Indirect Remuneration) contracts are very diverse. However, there is one common element: the expectation from payers/PBMs that…

Read More

Adherence interventions and artificial intelligence: an overview

Medication adherence is the biggest problem that healthcare keeps beating its collective head against. We have heard the numbers. US Pharmacist, in January 2018, cited statistics that nonadherence can account for up to 50% of treatment failures, around 125,000 deaths,…

Read More

Bowling with AllazoHealth!

  The AllazoHealth team at last week’s bowling event. It was part of our 2020-21 planning & innovation all-hands meeting in NYC.

Read More

11th Annual Medicaid Innovations Forum

Medicaid managed care plans: Achieve targeted HEDIS measures with improved adherence powered by AI Connect with AllazoHealth, February 5-7, 2020 Medicaid Innovations Forum  |  Hyatt Regency Grand Cypress | Orlando, Florida The Medicaid Innovations Forum is a highly anticipated annual event…

Read More

38th Annual J.P. Morgan Healthcare Conference

Healthcare Investors: Make AI your priority at the 38th Annual J.P. Morgan Healthcare Conference Connect with AllazoHealth, January 13–16, 2020 Westin St. Francis Hotel | San Francisco, California The annual J.P. Morgan Healthcare Conference is the largest and most informative…

Read More

RISE Star Ratings Master Class: December 12 – 13, 2019

Join Allazo at RISE Star Ratings Master Class December 12 - 13, 2019, Omni La Costa Resort & Spa, Carlsbad, CA Join AllazoHealth at the RISE Star Ratings Master Class. The program offers Medicare Advantage plans a deep dive into…

Read More

Meet us in Miami! Join AllazoHealth at the Fifth Medicare Star Ratings & Quality Assurance Summit

Meet us in Miami! Join AllazoHealth at the Fifth Medicare Star Ratings & Quality Assurance Summit December 2–4, 2019 at the Hilton Miami Downtown, Miami FL AllazoHealth will be in attendance along with 20 top-rated Medicare Advantage plans who’ll be…

Read More

Healthcare Industry News – November 2019

Comments on recent healthcare news articles, including using retail home delivery and transportation benefits to support adherence.
Read More

Healthcare Industry News – October 2019

Comments on recent healthcare news articles, including the ability to influence medication adherence through the use of smartphone apps, zero copay, and the availability of free medications
Read More

Optimize Performance Based Pharmacy Reimbursements

Over the last several years, PBMs and other payers have instituted performance-based contracts which leverage Direct and Indirect Remuneration fees to alter prescription-level reimbursement. While each individual contract can be complex, the burden placed on pharmacy organizations is magnified due to the wide variety of structures, measures, thresholds, and attribution methods.
Read More

CSS Health partners with AllazoHealth to offer a comprehensive patient engagement & medication adherence solution

Through targeted and personalized recommendations from AllazoHealth, CSS Health will be better able to more proactively influence at-risk members to ultimately make healthier choices about adherence.
Read More

AllazoHealth Welcomes Dr. Linda Schultz as Vice President of Customer Success

AllazoHealth, the healthcare technology company using Artificial Intelligence to predict and change patient behavior through precision engagement, announced today that Dr. Linda Schultz has joined the company as Vice President of Customer Success.
Read More

Lash Group to Amplify Patient Engagement Capabilities with AllazoHealth Artificial Intelligence and Predictive Analytics Tool

Lash Group, a patient support services company and a part of AmerisourceBergen, announced today that they will be partnering with AllazoHealth. The partnership will enhance patient adherence and engagement programs through targeted and personalized recommendations that will empower at-risk patients to ultimately make healthier choices.
Read More

Randomized Controlled Trial: Improving Medication Adherence with Artificial Intelligence

AllazoHealth has co-published a randomized controlled study with Blue Cross Blue Shield of North Carolina. “Improving Medication Adherence by Better Targeting Interventions Using Artificial Intelligence – a Randomized Controlled Trial”, was conducted for the health plan’s Medicare Advantage Part D (MAPD) population of 104,392 patients.
Read More

AllazoHealth Named As Top 40 Global Health Tech Innovation Startup

AllazoHealth was named one of the Top 40 Global HealthTech Innovation startups of 2019 by Accenture.
Read More

AllazoHealth Appoints Patient Services Innovator Steve Cohan as Advisor

AllazoHealth, the AI and predictive analytics company focused on predicting and changing patient behaviors through precision engagement, announced today that Steve Cohan will be joining the company’s Advisory Board.
Read More

AllazoHealth Hires Former CVS Executive as Growth Accelerates

AllazoHealth, the healthcare technology company using Artificial Intelligence to predict and change patient behavior through precision engagement, announced today that Bill Grambley has joined the company as Chief Operating Officer.
Read More

’Adherence Intelligence’ is the New AI – September 2018 MM&M feature article

In the September 2018 issue of MM&M, Davin Cho, VP of commercial strategy at AllazoHealth, outlines the future of medication adherence in the feature, “’Adherence Intelligence’ is the New AI”.
Read More

AllazoHealth Appoints New Board of Directors Member, Bill Moult

AllazoHealth announced today that Bill Moult, who has previously served as President and CEO at a number of respected marketing and media research & analytics organizations, will be appointed to the Board of Directors.
Read More

AllazoHealth CEO Clifford Jones Joins Takeda-Sponsored Panel at the 2018 APA Annual Meeting

The panel, titled “Enhanced patient support and engagement through digital innovation and artificial intelligence to improve adherence and clinical outcomes,” explored how new, innovative technologies are being deployed to improve medication adherence and clinical outcomes for patients.
Read More

The Halo Effect of Adherence to Anti-Depressants

A retrospective, cross-sectional analysis conducted across patients with concomitant use of anti-depressants with RAS antagonists, oral anti-diabetics, and/or statins.
Read More

AllazoHealth Wins 2017 FiercePharma Innovation Award

AllazoHealth the industry leader in optimizing medication adherence programs through artificial intelligence (AI), today announced that its AllazoEngine™ platform was named the winner of the Data Analytics & Business Intelligence category in the 2017 Fierce Innovation Awards: Life Sciences Edition.
Read More

Randomized Controlled Trial Validates Effectiveness of the AllazoHealth AI Engine

AllazoHealth has co-published a randomized controlled study with Blue Cross Blue Shield of North Carolina that validates the use of Artificial Intelligence in Improving Medication Adherence.
Read More

AllazoHealth to co-present randomized controlled, intent-to-treat study with BCBS of North Carolina at the 2017 Connected Health Conference

AllazoHealth and Blue Cross Blue Shield of North Carolina will co-present a poster at this year’s Connected Health Conference in Boston.
Read More

Why medication adherence is especially critical for diabetic patients

Adults with type 2 diabetes are at high risk for long-term complications, including cardiovascular disease (CVD), kidney disease, and nerve damage. They face shorter life expectancies — by about 10 years — and increased rates of hospitalizations.
Read More

AllazoHealth Publishes Poster in JMIR for the 13th Annual Connected Health Symposium

AllazoHealth has a published a study in JMIR following its poster presentation at the 13th Annual Connected Health Symposium. Completed in collaboration with The Solution Lab, the study is a comprehensive survey of managed care organization medication adherence intervention programs.
Read More

AllazoHealth Named One of 30 Top HealthTech Startups

AllazoHealth has been dubbed one of 30 healthtech startups with real potential to change the world, as presented by HealthTech’15: Fueling Innovation in Westchester.
Read More

AllazoHealth Awarded Finalist at MM&M Shark Tank Challenge

AllazoHealth was chosen as finalist in the MM&M Shark Tank Challenge, giving CEO Clifford Jones the opportunity to present his business model to seven pharma executives at the MM&M Transforming Healthcare conference in New York City.
Read More

PQA and AllazoHealth Announce Research Partnership

Pharmacy Quality Alliance (PQA, Inc.) and AllazoHealth have formed a formal research partnership to study and improve the medication adherence metrics used industry-wide.
Read More

AllazoHealth Chosen to Join the New York Digital Health Accelerator

The New York Digital Health Accelerator has selected AllazoHealth, along with six other startups, to participate in its 2014 class. The program will run for four months and during that time, startups will receive mentorship, attend workshops, and receive over $100,000 in capital investment.
Read More

Accountable Care Coalition of Greater New York and AllazoHealth Receive 2014 Pilot Health Tech Grant

The Accountable Care Coalition of Greater New York (ACCGNY) and AllazoHealth were awarded a significant grant by Pilot Health Tech NYC to address medication adherence among Medicare Fee-For-Service beneficiaries who are elderly or are intellectually/developmentally disabled (IDD).
Read More

AllazoHealth Presents at the 19th Annual Wharton Health Care Conference

AllazoHealth's CEO, Clifford Jones will be presenting at the 19th annual Wharton Health Care Conference on February 15, 2013.  Other speakers include Bruce Broussard, President and CEO of Humana; Gary L. Gottlieb, MD, President and CEO of Partners HealthCare; and Kent Thiry, Co-Chairman and CEO of DaVita.
Read More